These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 31266460

  • 1. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
    Rayes N, Bowen DJ, Coffin T, Nebgen D, Peterson C, Munsell MF, Gavin K, Lechner R, Crase J, Polinsky D, Romero I, Blank SV, Levine DA, Norquist BM, Swisher EM, Lu KH.
    BMC Cancer; 2019 Jul 02; 19(1):648. PubMed ID: 31266460
    [Abstract] [Full Text] [Related]

  • 2. Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.
    Swisher EM, Rayes N, Bowen D, Peterson CB, Norquist BM, Coffin T, Gavin K, Polinsky D, Crase J, Bakkum-Gamez JN, Blank SV, Munsell MF, Nebgen D, Fleming GF, Olopade OI, Law S, Zhou A, Levine DA, D'Andrea A, Lu KH.
    JAMA Oncol; 2023 Nov 01; 9(11):1547-1555. PubMed ID: 37707822
    [Abstract] [Full Text] [Related]

  • 3. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
    Kinney AY, Butler KM, Schwartz MD, Mandelblatt JS, Boucher KM, Pappas LM, Gammon A, Kohlmann W, Edwards SL, Stroup AM, Buys SS, Flores KG, Campo RA.
    J Natl Cancer Inst; 2014 Dec 01; 106(12):. PubMed ID: 25376862
    [Abstract] [Full Text] [Related]

  • 4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology.
    J Clin Oncol; 2003 Jun 15; 21(12):2397-406. PubMed ID: 12692171
    [Abstract] [Full Text] [Related]

  • 5. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
    Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, Chang Y, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Kinney AY, Luta G, Kelleher S, Leventhal KG, Vegella P, Tong A, King L.
    J Clin Oncol; 2014 Mar 01; 32(7):618-26. PubMed ID: 24449235
    [Abstract] [Full Text] [Related]

  • 6. Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
    McCuaig JM, Tone AA, Maganti M, Romagnuolo T, Ricker N, Shuldiner J, Rodin G, Stockley T, Kim RH, Bernardini MQ.
    Gynecol Oncol; 2019 Apr 01; 153(1):108-115. PubMed ID: 30638766
    [Abstract] [Full Text] [Related]

  • 7. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.
    J Natl Cancer Inst; 1997 Jan 15; 89(2):148-57. PubMed ID: 8998184
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population.
    Gilmore MJ, Leo MC, Amendola LM, Goddard KAB, Ezzell Hunter J, Joseph G, Kauffman TL, Rolf B, Shuster E, Zepp JM, Wilfond BS, Biesecker BB.
    Transl Behav Med; 2024 Jun 27; 14(7):377-385. PubMed ID: 38190737
    [Abstract] [Full Text] [Related]

  • 9. Web Platform vs In-Person Genetic Counselor for Return of Carrier Results From Exome Sequencing: A Randomized Clinical Trial.
    Biesecker BB, Lewis KL, Umstead KL, Johnston JJ, Turbitt E, Fishler KP, Patton JH, Miller IM, Heidlebaugh AR, Biesecker LG.
    JAMA Intern Med; 2018 Mar 01; 178(3):338-346. PubMed ID: 29356820
    [Abstract] [Full Text] [Related]

  • 10. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
    Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Gammon A, Butler K, Buys SS, Stroup AM, Campo RA, Flores KG, Mandelblatt JS, Schwartz MD.
    J Clin Oncol; 2016 Aug 20; 34(24):2914-24. PubMed ID: 27325848
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.
    Eijzenga W, Aaronson NK, Kluijt I, Sidharta GN, Hahn DE, Ausems MG, Bleiker EM.
    BMC Cancer; 2014 Jan 15; 14():26. PubMed ID: 24428912
    [Abstract] [Full Text] [Related]

  • 12. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E, Aalfs CM, Verdam MG, de Haes HC, Smets EM.
    Trials; 2014 Mar 20; 15():86. PubMed ID: 24649895
    [Abstract] [Full Text] [Related]

  • 13. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    Silverman TB, Vanegas A, Marte A, Mata J, Sin M, Ramirez JCR, Tsai WY, Crew KD, Kukafka R.
    BMC Health Serv Res; 2018 Aug 13; 18(1):633. PubMed ID: 30103738
    [Abstract] [Full Text] [Related]

  • 14. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
    Jacobs AS, Schwartz MD, Valdimarsdottir H, Nusbaum RH, Hooker GW, DeMarco TA, Heinzmann JE, McKinnon W, McCormick SR, Davis C, Forman AD, Lebensohn AP, Dalton E, Tully DM, Graves KD, Similuk M, Kelly S, Peshkin BN.
    Fam Cancer; 2016 Oct 13; 15(4):529-39. PubMed ID: 26969308
    [Abstract] [Full Text] [Related]

  • 15. IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.
    Cragun D, Beckstead J, Farmer M, Hooker G, Dean M, Matloff E, Reid S, Tezak A, Weidner A, Whisenant JG, Pal T.
    BMC Cancer; 2021 Oct 13; 21(1):1099. PubMed ID: 34645413
    [Abstract] [Full Text] [Related]

  • 16. Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.
    Steffen LE, Du R, Gammon A, Mandelblatt JS, Kohlmann WK, Lee JH, Buys SS, Stroup AM, Campo RA, Flores KG, Vicuña B, Schwartz MD, Kinney AY.
    Cancer Epidemiol Biomarkers Prev; 2017 Dec 13; 26(12):1772-1780. PubMed ID: 28971986
    [Abstract] [Full Text] [Related]

  • 17. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May 13; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R, Pan S, Silverman T, Zhang T, Chung WK, Terry MB, Fleck E, Younge RG, Trivedi MS, McGuinness JE, He T, Dimond J, Crew KD.
    JAMA Netw Open; 2022 Jul 01; 5(7):e2222092. PubMed ID: 35849397
    [Abstract] [Full Text] [Related]

  • 20. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
    Lumish HS, Steinfeld H, Koval C, Russo D, Levinson E, Wynn J, Duong J, Chung WK.
    J Genet Couns; 2017 Oct 01; 26(5):1116-1129. PubMed ID: 28357778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.